Episode 183 - Revolutionary tech for heart replacement - Thomas Vassiliades of BiVACOR

Thomas Vassiliades is the CEO of BiVACOR, a company that’s developing a medical device that can take over the complete function of a patient's heart. The company, which is headquartered in Houston but has the majority of its operations divided between California, Australia, and even parts of Europe, recently closed $18 million in funding to support its FDA clearance and pathway to clinical trials. Thomas joins the show today to explain the revolutionary technology and unique challenges he’s facing leading the company toward human implantation and eventually commercialization.